J A Melnikow

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Counterpoint: Randomized trials provide the strongest evidence for clinical guidelines: The US Preventive Services Task Force and Prostate Cancer Screening
    Joy Melnikow
    Department of Family and Community Medicine, Center for Healthcare Policy and Research, University of California, Davis, Sacramento, CA 95817, USA
    Med Care 51:301-3. 2013
  2. doi request reprint Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness
    Joy Melnikow
    Department of Economics, Center for Healthcare Policy and Research, University of California, Davis, California 95817, USA
    Obstet Gynecol 116:1158-70. 2010
  3. pmc Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study
    Joy Melnikow
    Department of Family and Community Medicine, Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA 95817, USA
    J Natl Cancer Inst 101:721-8. 2009
  4. doi request reprint Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis
    Joy Melnikow
    Department of Family and Community Medicine, University of California, Davis, Sacramento, California 95817, USA
    Med Care 46:946-53. 2008
  5. ncbi request reprint Chemoprevention: drug pricing and mortality: the case of tamoxifen
    Joy Melnikow
    Department of Family and Community Medicine, University of California Davis, Sacramento, California 95817, USA
    Cancer 107:950-8. 2006
  6. ncbi request reprint Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction
    Joy Melnikow
    Department of Family and Community Medicine, University of California Davis, Sacramento, California 95817, USA
    Cancer 103:1996-2005. 2005
  7. ncbi request reprint Management of the low-grade abnormal Pap smear: What are women's preferences?
    Joy Melnikow
    Department of Family and Community Medicine, University of California, Davis, Sacramento 95817, USA
    J Fam Pract 51:849-55. 2002
  8. ncbi request reprint Detection of high-grade cervical dysplasia: impact of age and Bethesda system terminology
    J Melnikow
    Department of Family and Community Medicine, University of California, Davis 95817, USA
    Diagn Cytopathol 17:321-5. 1997
  9. ncbi request reprint Natural history of cervical squamous intraepithelial lesions: a meta-analysis
    J Melnikow
    Department of Family and Community Medicine, University of California, Davis 95817, USA
    Obstet Gynecol 92:727-35. 1998
  10. ncbi request reprint Vaginal birth after cesarean in California
    J Melnikow
    Department of Family and Community Medicine, University of California, Davis, Sacramento, California 95817, USA
    Obstet Gynecol 98:421-6. 2001

Research Grants

Detail Information

Publications21

  1. doi request reprint Counterpoint: Randomized trials provide the strongest evidence for clinical guidelines: The US Preventive Services Task Force and Prostate Cancer Screening
    Joy Melnikow
    Department of Family and Community Medicine, Center for Healthcare Policy and Research, University of California, Davis, Sacramento, CA 95817, USA
    Med Care 51:301-3. 2013
    ....
  2. doi request reprint Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness
    Joy Melnikow
    Department of Economics, Center for Healthcare Policy and Research, University of California, Davis, California 95817, USA
    Obstet Gynecol 116:1158-70. 2010
    ..To estimate outcomes and costs of surveillance strategies after treatment for high-grade cervical intraepithelial neoplasia (CIN)...
  3. pmc Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study
    Joy Melnikow
    Department of Family and Community Medicine, Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA 95817, USA
    J Natl Cancer Inst 101:721-8. 2009
    ..Information on the long-term risk of cervical intraepithelial neoplasia (CIN) recurrence among women treated for CIN is limited yet critical for evidence-based surveillance recommendations...
  4. doi request reprint Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis
    Joy Melnikow
    Department of Family and Community Medicine, University of California, Davis, Sacramento, California 95817, USA
    Med Care 46:946-53. 2008
    ..In cost-effectiveness analysis (CEA), the effects of health-care interventions on multiple health dimensions typically require consideration of both quantity and quality of life...
  5. ncbi request reprint Chemoprevention: drug pricing and mortality: the case of tamoxifen
    Joy Melnikow
    Department of Family and Community Medicine, University of California Davis, Sacramento, California 95817, USA
    Cancer 107:950-8. 2006
    ..Tamoxifen is a prototypic cancer chemopreventive agent, yet clinical trials have not evaluated its effect on mortality or the impact of drug pricing on its cost-effectiveness...
  6. ncbi request reprint Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction
    Joy Melnikow
    Department of Family and Community Medicine, University of California Davis, Sacramento, California 95817, USA
    Cancer 103:1996-2005. 2005
    ..The objective of this study was to understand the attitudes and preferences of risk-eligible women regarding use of tamoxifen for breast cancer risk reduction...
  7. ncbi request reprint Management of the low-grade abnormal Pap smear: What are women's preferences?
    Joy Melnikow
    Department of Family and Community Medicine, University of California, Davis, Sacramento 95817, USA
    J Fam Pract 51:849-55. 2002
    ..To evaluate preferences among ethnically diverse women for the management of a low-grade abnormal Pap smear result: early colposcopy or observation with repeat Pap smears...
  8. ncbi request reprint Detection of high-grade cervical dysplasia: impact of age and Bethesda system terminology
    J Melnikow
    Department of Family and Community Medicine, University of California, Davis 95817, USA
    Diagn Cytopathol 17:321-5. 1997
    ..Consideration of patient age and whether HPV is the only Pap smear finding may reduce referral for immediate colposcopy...
  9. ncbi request reprint Natural history of cervical squamous intraepithelial lesions: a meta-analysis
    J Melnikow
    Department of Family and Community Medicine, University of California, Davis 95817, USA
    Obstet Gynecol 92:727-35. 1998
    ..To define the strengths and weaknesses of existing research on the natural history of cervical squamous intraepithelial lesions (SIL) and to estimate rates of progression and regression without treatment...
  10. ncbi request reprint Vaginal birth after cesarean in California
    J Melnikow
    Department of Family and Community Medicine, University of California, Davis, Sacramento, California 95817, USA
    Obstet Gynecol 98:421-6. 2001
    ..To estimate rates at which women were offered and consented to trial of labor in California hospitals with high and low risk-adjusted cesarean delivery rates...
  11. pmc Put prevention into practice: a controlled evaluation
    J Melnikow
    Department of Family and Community Medicine, University of California, Davis, USA
    Am J Public Health 90:1622-5. 2000
    ..The purpose of this study was to evaluate whether Put Prevention Into Practice (PPIP) materials affected the delivery of 8 clinical preventive services...
  12. ncbi request reprint Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
    J Melnikow
    Department of Family and Community Medicine, University of California Davis School of Medicine, Sacramento, USA
    Arch Fam Med 8:510-4. 1999
    ..To compare adherence to follow-up recommendations for colposcopy or repeated Papanicolaou (Pap) smears for women with previously abnormal Pap smear results...
  13. ncbi request reprint Recruitment strategies for minority participation: challenges and cost lessons from the POWER interview
    Janet Fulton Keyzer
    Center for Health Services Research in Primary Care, University of California, Davis, Sacramento, CA 95817, USA
    Ethn Dis 15:395-406. 2005
    ..The importance of recruiting and retaining women from diverse populations is well recognized; however, the recruitment process often presents greater challenges at higher costs than initially anticipated...
  14. ncbi request reprint "I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction
    Debora A Paterniti
    Center for Health Services Research in Primary Care, University of California, Davis, Sacramento, CA 95817, USA
    Ethn Dis 15:365-72. 2005
    ..To investigate how ethnically diverse women who are eligible for tamoxifen prophylaxis because of their breast cancer risk decide about tamoxifen use for risk reduction...
  15. ncbi request reprint Reporting number needed to treat and absolute risk reduction in randomized controlled trials
    Jim Nuovo
    Department of Family and Community Medicine, University of California, Davis, 4860 Y St, Sacramento, CA 95817, USA
    JAMA 287:2813-4. 2002
    ..We examined the frequency of explicit reporting of the number needed to treat (NNT) and the absolute risk reduction (ARR) in RCTs...
  16. ncbi request reprint Networked for change? Identifying obstetric opinion leaders and assessing their opinions on caesarean delivery
    Richard L Kravitz
    Center for Health Services Research in Primary Care, University of California, Davis, 4150 V Street Suite 2500, Sacramento, CA 95817, USA
    Soc Sci Med 57:2423-34. 2003
    ..However, they did not consistently support policies designed to reduce the caesarean delivery rate. The results have implications for the generalizability of opinion leader strategies...
  17. ncbi request reprint Do personal and societal preferences differ by socio-demographic group?
    Peter Franks
    Department of Family and Community Medicine, Center for Health Services Research in Primary Care, University of California, Sacramento, CA, USA
    Health Econ 16:319-25. 2007
    ..These preliminary findings suggest that using the EQ-5D Index in CEAs may not contribute to socio-demographic inequities...
  18. ncbi request reprint Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests
    Shalini L Kulasingam
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA
    Obstet Gynecol 107:321-8. 2006
    ..We estimated the cost-effectiveness of screening women with 3 or more prior normal tests compared with screening those with no prior tests...
  19. ncbi request reprint Human papillomavirus triage of atypical squamous cells of undetermined significance: cost-effective, but at what cost?
    Joy Melnikow
    J Natl Cancer Inst 98:82-3. 2006
  20. ncbi request reprint Risk of cervical cancer associated with extending the interval between cervical-cancer screenings
    George F Sawaya
    Department of Obstetrics, Gynecology, and Reproductive Sciences, Department of Veterans Affairs and University of California, San Francisco, San Francisco, USA
    N Engl J Med 349:1501-9. 2003
    ....
  21. ncbi request reprint Conservative versus aggressive follow up of mildly abnormal Pap smears: testing for process utility
    Stephen Birch
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada
    Health Econ 12:879-84. 2003
    ..We also found that relative preferences among different processes may depend on the particular circumstances or pathologies being considered...

Research Grants8

  1. TAMOXIFEN & BREAST CANCER--ACCEPTANCE/COST EFFECTIVENESS
    Joy Melnikow; Fiscal Year: 2002
    ..abstract_text> ..
  2. Surveillance Strategies Following Treatment for CIN
    Joy Melnikow; Fiscal Year: 2007
    ..Alternative strategies for post-treatment surveillance will be evaluated. ..